Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Contributed by: PR Newswire

Tags

Sobi-Innate-Partners

More Like This

Sobi and Innate announce partnership is now effective following completion of closing conditions

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi showcases new data across rare inflammatory conditions at ACR 2025

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

Business Wire logo

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors

Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam

Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024

Sobi to share new clinical data and research at EULAR 2025